Keytruda® WHAT IS KEYTRUDA®? 1. KEYTRUDA ® is a high-affinity, humanised monoclonal antibody designed to block the interaction between the immune checkpoint receptor, […]
KEYTRUDA® + LENVIMA® Consider KEYTRUDA® + LENVIMA® for your appropriate patients with advanced endometrial carcinoma that is not MSI-H or dMMR, who have […]
LAGEVRIO® More about LAGEVRIO® COVID-19=coronavirus disease 2019. References: LAGEVRIO® Prescribing Information, Malaysia, March 2022. MY-LAG-00007 Oct/2022
LENVIMA WHAT IS LENVIMA®? 1. LENVIMA® is a multitargeted tyrosine kinase inhibitor (TKI), which has broad antitumor and antiangiogenic activity.12. It […]
Protected: Locally recurrent unresectable or metastatic triple-negative breast cancer- test There is no excerpt because this is a protected post.
M-M-R®II M-M-R®II Product Overview References: Nytimes.com. (2019). A Forgotten Pioneer of Vaccines. [online] Available From: https://www.nytimes.com/2013/05/07/ health/maurice-hilleman-M-M-R-vaccinesforgotten-hero.html?_r=0 Last Accessed: 17th October […]
Pneumovax® 23 Product Overview What is PNEUMOVAX® 23?1 Pneumovax® 23 is indicated to help prevent pneumococcal disease caused by 23 serotypes included […]